IP Verse

Sanofi Aventis Deutschland vs. Amgen - UPC_CFI_1/2023

The UPC Case UPC_CFI_1/2023 was filed on 02 Jun, 2023 by the plaintiff Sanofi Aventis Deutschland against the defendant Amgen.

Case Details

    Case Number:

    UPC_CFI_1/2023

    Patent Number:

    EP3666797

    Filing Date:

    02 Jun, 2023

    Proceeding Type:

    Revocation

    Case Phase:

    Case Closed

    Plaintiffs:

    • Sanofi Aventis Deutschland

    Plaintiff Representatives:

    • Daniel WISE

    Defendants:

    • Amgen

    Defendant Representatives:

    • Koen BIJVANK

    Judges:

    • Andras Kupecz
    • Casper Struve
    • Ulrike Voß

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

DateTitleLink
Oct 23, 2024Procedural Order App 47172-
Oct 23, 2024Procedural Order App 47163-
Jul 16, 2024Final Order Anonymised-
Jul 16, 2024Decision Revocation Action 1
Jul 16, 2024Decisionoutcome-
Jul 4, 2024Announcement
Jun 5, 2024Oral Hearing Referencing 459505-
May 22, 2024Interimprocedureclosure-
May 13, 2024Receipt-
May 10, 2024Amgen Slides-
May 10, 2024Amgen R 9 Appl Filing Slides-
May 10, 2024.05.10 Sanofi And Regeneron Slides Signed-
May 10, 2024.05.10 Sanofi And Regeneron Slide Reference Table Signed-
May 10, 2024.05.10 Cover Letter Accompanying Slides Signed-
May 7, 2024Receipt-
May 7, 2024Outcome Of The Order-
May 7, 2024Order Re Admission Of Documents
May 7, 2024Extension Order Slides
May 6, 2024Extension Request-
May 3, 2024Amgen Reply To Prel Order 30 April-
Apr 30, 2024Po-
Apr 30, 2024Outcome Of The Order-
Apr 30, 2024Order Closing Workflow-
Apr 26, 2024Receipt-
Apr 26, 2024C54A Amgen Infringement Claim (En Translation)-
Apr 26, 2024C37A US60 818234 (Priority Document To Bms Patent Application) (Signed)-
Apr 26, 2024Annex 1 Updated Consolidated List Of Exhibits And Evidence (Signed)-
Apr 26, 2024.04.26 Rop 9.1 Application Re C37A (Signed)-
Apr 19, 2024Writtenprocedureclosure-
Apr 19, 2024Summons Oral Hearing
Apr 19, 2024Summons-
Apr 19, 2024Hearing Dates-
Apr 5, 2024Receipt-
Apr 5, 2024Case Summary-
Apr 5, 2024Annex 2 Notice Of Experts (Signed)-
Apr 5, 2024Annex 1 CR OSS Reference Table (Signed)-
Apr 5, 2024Amgen Response Cd To Sanofi Submission Re Pan Declaration-
Apr 5, 2024Amgen Cover Letter Case Summary-
Apr 5, 2024.04.05 Claimants Case Summary Signed-
Apr 5, 2024.03.07 Reply To Amgen Defence To The Counterclaim For Invalidity (Signed)-
Mar 7, 2024.03.07 Reply To Amgen Defence To The Counterclaim For Invalidity (Signed)-
Mar 4, 2024Order To Combine Cases Act 459505 And Cc 586764-
Feb 27, 2024Order To Combine Cases-
Feb 6, 2024Receipt-
Feb 5, 2024Order Local Division 2 February-
Feb 5, 2024Exhibit-
Feb 5, 2024D99 Edrees Et Al-
Feb 5, 2024C10A Priority Document-
Feb 5, 2024Application For A Procedural Order Pursuant To Rule 9(1) Rop-
Feb 5, 2024Application-
Jan 24, 2024Rop 9.1 Order Final-
Jan 24, 2024Outcome Of The Order-
Jan 19, 2024Amgen Response Cd Order Rule 9 Application-
Jan 17, 2024Representation-
Jan 16, 2024Template Order-
Jan 16, 2024Receipt-
Jan 16, 2024Preliminary Order 16 January Rop 9-
Jan 16, 2024Acknowledgement Of Change Of A Representative-
Jan 15, 2024Rejoinder To Reply To Defence To Application To Amend-
Jan 15, 2024Rejoinamendpatentdefence-
Jan 15, 2024Exhibit E15-
Jan 15, 2024Exhibit E14-
Jan 15, 2024Exhibit E13-
Jan 15, 2024Exhibit C114-
Jan 15, 2024Exhibit C113-
Jan 15, 2024Exhibit C112-
Jan 15, 2024Application-
Jan 9, 2024Formal Checks Notification Of Positive Outcome-
Jan 9, 2024App R293 Receipt-
Dec 22, 2023Explanations Re Application For Change Of Representative (R. 293 Rop)-
Dec 22, 2023Acknowledgement Of Lodging-
Dec 13, 2023Replyamendpatentdefence-
Dec 13, 2023Defendants Reply To Claimants Defence To Application To Amend-
Dec 13, 2023Defendants Rejoinder To Reply To Defence (13.12.)-
Dec 13, 2023D98 Internal Amgen Research Document ()-
Dec 13, 2023D97 Transcript Of Feb 22, Trial Hearing (S. Jackson)-
Dec 13, 2023D96 Mgi Mouse Facts-
Dec 13, 2023D95 Horton Parker Joint Expert Report-
Dec 13, 2023D94 Weider-
Dec 13, 2023D93 O. Pan Declaration-
Dec 13, 2023D92 US8710192B2 (Novartis)-
Dec 13, 2023D91 Lin-
Dec 13, 2023D90 Oltersdorf-
Dec 13, 2023D89 Wells And Clendon-
Dec 13, 2023D88 Arkin And Wells-
Dec 13, 2023D87 Wetterau 1998-
Dec 13, 2023D86 Benjannet-
Dec 13, 2023D85 Abstract Book Pcsk9 Conference Nantes ()-
Dec 13, 2023D84 Fraser 1995-
Dec 13, 2023D83 Wight And Merrilees-
Dec 13, 2023D82 Chan-
Dec 13, 2023D81 Prof. Boyd'S Chart From Us Proceedings-
Dec 13, 2023D80 Paul-
Dec 13, 2023D79 Dubuc-
Dec 13, 2023D78 Dunbar-
Dec 13, 2023D77 Brunzelle-
Dec 13, 2023D76 Hansen-
Dec 13, 2023D75 Blundell-
Dec 13, 2023D74 Blundell-
Dec 13, 2023D73 Manjasetty-
Dec 13, 2023D72 Mcpherson-
Dec 13, 2023D71 Ladner-
Dec 13, 2023D70 Sandin-
Dec 13, 2023Annex 1 Updated List Of Cited Documents Defendant Amgen-
Dec 13, 2023Acknowledgement Of Lodging-
Dec 13, 20232Nd Declaration Of Prof. A. Rees-
Dec 13, 20232Nd Declaration Of Dr. R. Parker-
Dec 5, 2023Amendpatentdefence-
Dec 5, 2023.11.13 Sanofi Cd Reply To Defence Signed-
Dec 4, 2023Receipt-
Dec 4, 2023Formal Checks Notification Of Positive Outcome-
Dec 4, 2023Defendant Amgens Application To Amend (Ar1 Ar17)-
Dec 4, 2023Auxiliary Requests Ar1 Ar17 (Marked Up Versions)-
Dec 4, 2023Auxiliary Requests Ar1 Ar17 (Clean Version)-
Dec 4, 2023Acknowledgement Of Lodging-
Dec 1, 2023Defendants Defence To Revocation (Includes Application To Amend)-
Dec 1, 2023Auxiliary Requests Ar1 17 (Marked Up Version)-
Dec 1, 2023Auxiliary Requests Ar1 17 (Clean Version)-
Nov 27, 2023Outcome Of The Order-
Nov 27, 2023Closing Workflow-
Nov 22, 2023Rop 9.3(A) Order-
Nov 22, 2023Receipt-
Nov 22, 2023Outcome Of The Order-
Nov 21, 2023Defandants Additional Comments Re Rule 9.3 Rop (Time Extension Request)-
Nov 20, 2023Response To Amgen Request 587598 For An Extension To Rejoinder-
Nov 20, 2023Preliminary Order Rop 9.3(A)-
Nov 17, 2023Response To Amgen Request 587598 For An Extension To Rejoinder-
Nov 17, 2023Receipt-
Nov 16, 2023Reasoned Request (Time Extension) Pursuant To Rule 9 Rop-
Nov 13, 2023E9 Signed-
Nov 13, 2023E8 Signed-
Nov 13, 2023E7 Signed-
Nov 13, 2023E10 Signed-
Nov 13, 2023C99 Signed-
Nov 13, 2023C98 Signed-
Nov 13, 2023C97 Signed-
Nov 13, 2023C96 Signed-
Nov 13, 2023C95 Signed-
Nov 13, 2023C94 Signed-
Nov 13, 2023C93 Signed-
Nov 13, 2023C92 Signed-
Nov 13, 2023C91 Signed-
Nov 13, 2023C90 Signed-
Nov 13, 2023C89 Signed-
Nov 13, 2023C88 Signed-
Nov 13, 2023C87 Signed-
Nov 13, 2023C86 Signed-
Nov 13, 2023C85 Signed-
Nov 13, 2023C84 Signed-
Nov 13, 2023C83 Signed-
Nov 13, 2023C82 Signed-
Nov 13, 2023C81 Signed-
Nov 13, 2023C80 Signed-
Nov 13, 2023C79 Signed-
Nov 13, 2023C78 Signed-
Nov 13, 2023C77 Signed-
Nov 13, 2023C76 Signed-
Nov 13, 2023C75 Signed-
Nov 13, 2023C74 Signed-
Nov 13, 2023C73 Signed-
Nov 13, 2023C72 Signed-
Nov 13, 2023C71 Signed-
Nov 13, 2023C70 Signed-
Nov 13, 2023C69 Signed-
Nov 13, 2023C68 Signed-
Nov 13, 2023C67 Signed-
Nov 13, 2023C66 Signed-
Nov 13, 2023C65 Signed-
Nov 13, 2023C64 Signed-
Nov 13, 2023C63 Signed-
Nov 13, 2023C62 Signed-
Nov 13, 2023C61 Signed-
Nov 13, 2023C60 Signed-
Nov 13, 2023C59 Signed-
Nov 13, 2023C58 Signed-
Nov 13, 2023C57 Signed-
Nov 13, 2023C56 Signed-
Nov 13, 2023C55 Signed-
Nov 13, 2023C54 Signed-
Nov 13, 2023C38A Signed-
Nov 13, 2023C111 Signed-
Nov 13, 2023C110 Signed-
Nov 13, 2023C109 Signed-
Nov 13, 2023C108 Signed-
Nov 13, 2023C107 Signed-
Nov 13, 2023C106 Signed-
Nov 13, 2023C105 Signed-
Nov 13, 2023C104 Signed-
Nov 13, 2023C103 Signed-
Nov 13, 2023C102 Signed-
Nov 13, 2023C101 Signed-
Nov 13, 2023C100 Signed-
Nov 13, 2023Acknowledgement Of Lodging-
Nov 13, 2023.11.13 Sanofi Cd Reply To Defence Signed-
Oct 16, 2023Order Rop 28 DATED 16 October-
Oct 16, 2023Official Date-
Oct 11, 2023Reply To Preliminary Order Setting Provisional Dates (Signed)-
Oct 9, 2023Defendants Reply To Po No. 577997 (No Objections)-
Oct 4, 2023Provisional Date-
Oct 4, 2023Preliminary Order Rule 28 Rop-
Sep 14, 2023Formal Checks Notification Of Positive Outcome-
Sep 14, 2023Acknowledgement Of Lodging-
Sep 12, 2023E6 Declaration Of Prof. T. Rees (With Cv)-
Sep 12, 2023E5 Declaration Of Dr R. Parker (With Cv)-
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part Iv-
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part Iii-
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part Ii-
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part I-
Sep 12, 2023Defendant Amgen'S Defence To Revocation-
Sep 12, 2023D9 CR OOKE-
Sep 12, 2023D8 Ni Et Al.-
Sep 12, 2023D7 Kruth-
Sep 12, 2023D6 Wo /057457 A2-
Sep 12, 2023D69 Examiner Notes About Irrelevance Of Tpos (March 27,)-
Sep 12, 2023D68 Examiner Interview Notes Re Tpos (March 15,)-
Sep 12, 2023D67 Examiner Interview Notes (March 1,)-
Sep 12, 2023D66 Bell-
Sep 12, 2023D65 Subramaniam-
Sep 12, 2023D64 Choi-
Sep 12, 2023D63 Spencer-
Sep 12, 2023D62 Novotny 1983-
Sep 12, 2023D61 Jia-
Sep 12, 2023D60 Soto-
Sep 12, 2023D5 Wo /043753 A2-
Sep 12, 2023D59 Hu-
Sep 12, 2023D58 Paull-
Sep 12, 2023D57 Nature Editorial-
Sep 12, 2023D56 Parameswaran And Liu-
Sep 12, 2023D55 Rudenko Full Validation Report-
Sep 12, 2023D54 Degenst-
Sep 12, 2023D53 Pedrioli And Oxenius-
Sep 12, 2023D52 Perelson Weisbuch 1995-
Sep 12, 2023D51 Raybould-
Sep 12, 2023D50 Edwards-
Sep 12, 2023D4 Kastelein-
Sep 12, 2023D49 Rudenko-
Sep 12, 2023D48 Baerga Ortiz-
Sep 12, 2023D47 Glaser 1992-
Sep 12, 2023D46 Maccallum 1996-
Sep 12, 2023D45 Ye-
Sep 12, 2023D44 Chowdhury 1999-
Sep 12, 2023D43 Roberts 1987-
Sep 12, 2023D42 Us 8,357,371 B2-
Sep 12, 2023D41 EP2358756B1-
Sep 12, 2023D40 Declaration Of Wei Wang-
Sep 12, 2023D40B Appendix B Wang Lab Notebook-
Sep 12, 2023D40A Appendix A Wang Lab Notebook-
Sep 12, 2023D3 Frank Kamenetsky Et Al.-
Sep 12, 2023D39 Declaration Of Kelly Berry-
Sep 12, 2023D38 Kondrashov-
Sep 12, 2023D37 Rees-
Sep 12, 2023D36 Baran-
Sep 12, 2023D35 Lo Surdo-
Sep 12, 2023D34 Eliassen-
Sep 12, 2023D33 Esteve-
Sep 12, 2023D32 Mitchell-
Sep 12, 2023D31 Us 8,420,098 B2-
Sep 12, 2023D30 Horton-
Sep 12, 2023D2 Us 7,737,266 B2 (Alnylam)-
Sep 12, 2023D29 Wo /1057797-
Sep 12, 2023D28 Press Release Bms Isis-
Sep 12, 2023D27 Poirier-
Sep 12, 2023D26 Poirier-
Sep 12, 2023D25 Mcnutt-
Sep 12, 2023D24 Us /0275053-
Sep 12, 2023D23 Grefhorst-
Sep 12, 2023D22 Ioannidis-
Sep 12, 2023D21 Homer-
Sep 12, 2023D20 Nassoury-
Sep 12, 2023D1 Seeking Alpha Alnylam-
Sep 12, 2023D19 Graham-
Sep 12, 2023D18 Seidah-
Sep 12, 2023D17 Maxwell-
Sep 12, 2023D16 Horton-
Sep 12, 2023D15 Lagace Supplemental Data To C3-
Sep 12, 2023D14 Havel And Hamilton-
Sep 12, 2023D13 Mccuskey-
Sep 12, 2023D12 Brown And Goldstein 1979-
Sep 12, 2023D11 Brown And Goldstein 1986-
Sep 12, 2023D10 Bell-
Sep 12, 2023Ar1 Ar17 (Marked Up)-
Sep 12, 2023Ar1 Ar17 (Clean Version)-
Sep 12, 2023Annex 2 Aso Technology-
Sep 12, 2023Annex 1 List Of Cited Documents Defendant Amgen-
Aug 24, 2023Preliminary Objection Decisionoutcome-
Aug 24, 2023Order Rejecting Preliminary Objection DATED 24 August-
Aug 23, 2023554674/Oh/2Mu/Upc202308173Pm-
Aug 21, 2023Outcome Of The Order-
Aug 21, 2023Order Re 9.3(A) Request Granting 2 Weeks Extension-
Aug 21, 2023Comments Pursuant To Rop264-
Aug 18, 2023Outcome Of The Order-
Aug 18, 2023Order Closing Application-
Aug 17, 2023Re Rule 9.3(A) Request Closing This Application-
Aug 17, 2023Receipt-
Aug 17, 2023Preliminary Order 17 August Rule 9 Application-
Aug 17, 2023Outcome Of The Order-
Aug 17, 2023Letter Adding Co Representatives 17 Aug (Signed)-
Aug 16, 2023Supplementary Submission To Extension Request-
Aug 16, 2023Public Attendance Order Hearing-
Aug 16, 2023Order Re Public Attendance Po Hearing (Ord 562392 2023)-
Aug 16, 2023Order Re Public Attendance Po Hearing-
Aug 16, 2023Application-
Aug 15, 2023Submission In Reply To Claimants Response To Preliminary Objection (Rule 49.1 Rop)-
Aug 15, 2023Reasoned Request Pursuant To Rule 9 Rop-
Aug 9, 2023Hearing Invitation 17 August 1500-
Aug 9, 2023Hearing Dates-
Aug 8, 2023Exhibit CR PO 6B Signed-
Aug 8, 2023Exhibit CR PO 6A Signed-
Aug 8, 2023Exhibit CR PO 5B Signed-
Aug 8, 2023Exhibit CR PO 5A Signed-
Aug 8, 2023Exhibit CR PO 4B Signed-
Aug 8, 2023Exhibit CR PO 4A Signed-
Aug 8, 2023Exhibit CR PO 3 Signed-
Aug 8, 2023Exhibit CR PO 2 Signed-
Aug 8, 2023Exhibit CR PO 1 Signed-
Aug 8, 2023Commentpreliminaryobjection-
Aug 8, 2023Comment On Preliminary Objection-
Aug 8, 2023Annex To Exhibit CR PO 2 Signed-
Aug 4, 2023Template Order-
Jul 31, 2023Receipt-
Jul 28, 2023.07.28 Withdrawal Of Document Request Action No 459505 Signed Agc-
Jul 25, 2023Preliminary Objection Of Defendant (R. 48 And R. 19.1 Rop)-
Jul 25, 2023Preliminaryobjection-
Jul 25, 2023Formal Checks Request For Correction-
Jul 25, 2023Exhibit Ed 2-
Jul 25, 2023Exhibit Ed 1-
Jul 21, 2023Preliminary Objection According To R. 48 And R 19.1 Rop-
Jul 21, 2023Exhibit Ed2-
Jul 21, 2023Exhibit Ed1-
Jul 17, 2023Formal Checks Request For Correction-
Jul 12, 2023Reply Of Defendant (Amgen) To Intended Appointment Of Tqj-
Jul 12, 2023Acknowledgement Of Lodging-
Jul 5, 2023Acknowledgement Of Adding A Missing Party Or Applicant-
Jun 29, 2023Upc Cfi 1 Formal Response To The Procedural Order Of The Court 536514 2023 Dated Signed-
Jun 29, 2023Outcome Of The Order-
Jun 29, 2023Order Generic Application-
Jun 29, 2023Acknowledgement Of Access To Case-
Jun 27, 2023Receipt-
Jun 23, 2023Rule 9 Order Final-
Jun 23, 2023Payment Receipt Signed-
Jun 23, 2023P4B 61 086133 Signed-
Jun 23, 2023P4A 61 086133 Signed-
Jun 23, 2023P3G 61 010630 Signed-
Jun 23, 2023P3F 61 010630 Signed-
Jun 23, 2023P3E 61 010630 Signed-
Jun 23, 2023P3D 61 010630 Signed-
Jun 23, 2023P3C 61 010630 Signed-
Jun 23, 2023P3B 61 010630 Signed-
Jun 23, 2023P3A 61 010630 Signed-
Jun 23, 2023P2B 61 008965 Signed-
Jun 23, 2023P2A 61 008965 Signed-
Jun 23, 2023P1 60 957668 Signed-
Jun 23, 2023Notification Of Service-
Jun 23, 2023Letter For Service-
Jun 23, 2023E4 Zwicker Declaration Signed-
Jun 23, 2023E3 Boyd Declaration Cv Signed-
Jun 23, 2023E2 Horton Declaration Cv Signed-
Jun 23, 2023E1 Schwartz Declaration Citations Signed-
Jun 23, 2023C9 Mcnutt Signed-
Jun 23, 2023C8 Cunningham Signed-
Jun 23, 2023C7 Fisher Signed-
Jun 23, 2023C6 Qian Signed-
Jun 23, 2023C5 Kwon Signed-
Jun 23, 2023C53 European Patent Register For .4 Signed-
Jun 23, 2023C52 National Register Extracts Signed-
Jun 23, 2023C51 Maggon Signed-
Jun 23, 2023C50 Weiner Signed-
Jun 23, 2023C4 Zhang Signed-
Jun 23, 2023C49 Wo 077854 Signed-
Jun 23, 2023C49A US61 168753 Signed-
Jun 23, 2023C48 Duff Signed-
Jun 23, 2023C47 Glennie And Johnson Signed-
Jun 23, 2023C46 Hoogenboom And Chames Signed-
Jun 23, 2023C45 Claims Filed In November And Sections Of Response Signed-
Jun 23, 2023C44 Claims Filed With Response To Eesr And Sections Of Response Signed-
Jun 23, 2023C43 Claims And Accompanying Letter Feb Signed-
Jun 23, 2023C42 Zhao Signed-
Jun 23, 2023C41 Kuroda Signed-
Jun 23, 2023C40 Summary Of European National Case Law On Sufficiency Of Disclosure Signed-
Jun 23, 2023C3 Lagace Signed-
Jun 23, 2023C39 Brown Goldstein Signed-
Jun 23, 2023C38 WO2009055783 Signed-
Jun 23, 2023C37B WO2008105797 Signed-
Jun 23, 2023C37A WO2008105797 Signed-
Jun 23, 2023C36 Seidah Signed-
Jun 23, 2023C35 Goldstein Brown 1975 Signed-
Jun 23, 2023C34D Turk Signed-
Jun 23, 2023C34C Turk Signed-
Jun 23, 2023C34B Turk Signed-
Jun 23, 2023C34A Turk Signed-
Jun 23, 2023C33 Benjannet Signed-
Jun 23, 2023C32 Park Signed-
Jun 23, 2023C31B Sun Signed-
Jun 23, 2023C31A Sun Signed-
Jun 23, 2023C30 Berge Signed-
Jun 23, 2023C2 Wo 100318 Signed-
Jun 23, 2023C2C Gao Signed-
Jun 23, 2023C2B Pct Request For C2 Signed-
Jun 23, 2023C2A US61 063980 Signed-
Jun 23, 2023C29 Abifadel Signed-
Jun 23, 2023C28 Cohen Signed-
Jun 23, 2023C27 Maxwell Signed-
Jun 23, 2023C26 Holla Signed-
Jun 23, 2023C25 Rashid Signed-
Jun 23, 2023C24B Hoogenboom Signed-
Jun 23, 2023C24A Hoogenboom Signed-
Jun 23, 2023C23 Antibody Engineering Methods And Protocols Signed-
Jun 23, 2023C22 Phage Display A Laboratory Manual Signed-
Jun 23, 2023C21 Cameron Signed-
Jun 23, 2023C20 Bottomley Signed-
Jun 23, 2023C1 Wo 100297 Signed-
Jun 23, 2023C1F Ni Signed-
Jun 23, 2023C1E Wikipedia Simvastatin Signed-
Jun 23, 2023C1D Preliminary Opinion Of The Enlarged Board In G1 22 And G2 22 Signed-
Jun 23, 2023C1C Pct Request For C1 Signed-
Jun 23, 2023C1B US61 066577 Signed-
Jun 23, 2023C1A US61 063949 Signed-
Jun 23, 2023C19 Ramasamy Signed-
Jun 23, 2023C18 Sarkar Et Al Signed-
Jun 23, 2023C17 Seidah And Prat Signed-
Jun 23, 2023C16 Cohen Signed-
Jun 23, 2023C15 Seidah Signed-
Jun 23, 2023C14 Lopez Signed-
Jun 23, 2023C13 Hampton Signed-
Jun 23, 2023C12 Piper Signed-
Jun 23, 2023C11 Horton Signed-
Jun 23, 2023C10 Wo 125623 Signed-
Jun 23, 2023B1V EP3666797 Signed-
Jun 23, 2023B1U EP3666797 Signed-
Jun 23, 2023B1T EP3666797 Signed-
Jun 23, 2023B1S EP3666797 Signed-
Jun 23, 2023B1R EP3666797 Signed-
Jun 23, 2023B1Q EP3666797 Signed-
Jun 23, 2023B1P EP3666797 Signed-
Jun 23, 2023B1O EP3666797 Signed-
Jun 23, 2023B1N EP3666797 Signed-
Jun 23, 2023B1M EP3666797 Signed-
Jun 23, 2023B1L EP3666797 Signed-
Jun 23, 2023B1K EP3666797 Signed-
Jun 23, 2023B1J EP3666797 Signed-
Jun 23, 2023B1I EP3666797 Signed-
Jun 23, 2023B1H EP3666797 Signed-
Jun 23, 2023B1G EP3666797 Signed-
Jun 23, 2023B1F EP3666797 Signed-
Jun 23, 2023B1E EP3666797 Signed-
Jun 23, 2023B1D EP3666797 Signed-
Jun 23, 2023B1C EP3666797 Signed-
Jun 23, 2023B1B EP3666797 Signed-
Jun 23, 2023B1A EP3666797 Signed-
Jun 23, 2023A1F Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1E Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1D Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1C Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1B Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1A Wo 026558 Pct Application As Filed Signed-
Jun 20, 2023Panel Appointment-
Jun 2, 2023Statementofrevocation-
Jun 2, 2023Formal Checks Notification Of Positive Outcome-
Jun 1, 2023Sanofi V Amgen Revocation Action EP3666797 Signed V2-
Jun 1, 2023Letter To Registry Sanofi V Amgen Uploading Issues On Signed-
Jun 1, 2023.06.01 Letter To The Upc Lodging Of Revocation Action-
Oct 23, 2024Procedural Order App 47172-
Oct 23, 2024Procedural Order App 47163-
Jul 16, 2024Final Order Anonymised-
Jul 16, 2024Decision Revocation Action 1
Jul 16, 2024Decisionoutcome-
Jul 4, 2024Announcement
Jun 5, 2024Oral Hearing Referencing 459505-
May 22, 2024Interimprocedureclosure-
May 13, 2024Receipt-
May 10, 2024Amgen Slides-
May 10, 2024Amgen R 9 Appl Filing Slides-
May 10, 2024.05.10 Sanofi And Regeneron Slides Signed-
May 10, 2024.05.10 Sanofi And Regeneron Slide Reference Table Signed-
May 10, 2024.05.10 Cover Letter Accompanying Slides Signed-
May 7, 2024Receipt-
May 7, 2024Outcome Of The Order-
May 7, 2024Order Re Admission Of Documents
May 7, 2024Extension Order Slides
May 6, 2024Extension Request-
May 3, 2024Amgen Reply To Prel Order 30 April-
Apr 30, 2024Po-
Apr 30, 2024Outcome Of The Order-
Apr 30, 2024Order Closing Workflow-
Apr 26, 2024Receipt-
Apr 26, 2024C54A Amgen Infringement Claim (En Translation)-
Apr 26, 2024C37A US60 818234 (Priority Document To Bms Patent Application) (Signed)-
Apr 26, 2024Annex 1 Updated Consolidated List Of Exhibits And Evidence (Signed)-
Apr 26, 2024.04.26 Rop 9.1 Application Re C37A (Signed)-
Apr 19, 2024Writtenprocedureclosure-
Apr 19, 2024Summons Oral Hearing
Apr 19, 2024Summons-
Apr 19, 2024Hearing Dates-
Apr 5, 2024Receipt-
Apr 5, 2024Case Summary-
Apr 5, 2024Annex 2 Notice Of Experts (Signed)-
Apr 5, 2024Annex 1 CR OSS Reference Table (Signed)-
Apr 5, 2024Amgen Response Cd To Sanofi Submission Re Pan Declaration-
Apr 5, 2024Amgen Cover Letter Case Summary-
Apr 5, 2024.04.05 Claimants Case Summary Signed-
Apr 5, 2024.03.07 Reply To Amgen Defence To The Counterclaim For Invalidity (Signed)-
Mar 7, 2024.03.07 Reply To Amgen Defence To The Counterclaim For Invalidity (Signed)-
Mar 4, 2024Order To Combine Cases Act 459505 And Cc 586764-
Feb 27, 2024Order To Combine Cases-
Feb 6, 2024Receipt-
Feb 5, 2024Order Local Division 2 February-
Feb 5, 2024Exhibit-
Feb 5, 2024D99 Edrees Et Al-
Feb 5, 2024C10A Priority Document-
Feb 5, 2024Application For A Procedural Order Pursuant To Rule 9(1) Rop-
Feb 5, 2024Application-
Jan 24, 2024Rop 9.1 Order Final-
Jan 24, 2024Outcome Of The Order-
Jan 19, 2024Amgen Response Cd Order Rule 9 Application-
Jan 17, 2024Representation-
Jan 16, 2024Template Order-
Jan 16, 2024Receipt-
Jan 16, 2024Preliminary Order 16 January Rop 9-
Jan 16, 2024Acknowledgement Of Change Of A Representative-
Jan 15, 2024Rejoinder To Reply To Defence To Application To Amend-
Jan 15, 2024Rejoinamendpatentdefence-
Jan 15, 2024Exhibit E15-
Jan 15, 2024Exhibit E14-
Jan 15, 2024Exhibit E13-
Jan 15, 2024Exhibit C114-
Jan 15, 2024Exhibit C113-
Jan 15, 2024Exhibit C112-
Jan 15, 2024Application-
Jan 9, 2024Formal Checks Notification Of Positive Outcome-
Jan 9, 2024App R293 Receipt-
Dec 22, 2023Explanations Re Application For Change Of Representative (R. 293 Rop)-
Dec 22, 2023Acknowledgement Of Lodging-
Dec 13, 2023Replyamendpatentdefence-
Dec 13, 2023Defendants Reply To Claimants Defence To Application To Amend-
Dec 13, 2023Defendants Rejoinder To Reply To Defence (13.12.)-
Dec 13, 2023D98 Internal Amgen Research Document ()-
Dec 13, 2023D97 Transcript Of Feb 22, Trial Hearing (S. Jackson)-
Dec 13, 2023D96 Mgi Mouse Facts-
Dec 13, 2023D95 Horton Parker Joint Expert Report-
Dec 13, 2023D94 Weider-
Dec 13, 2023D93 O. Pan Declaration-
Dec 13, 2023D92 US8710192B2 (Novartis)-
Dec 13, 2023D91 Lin-
Dec 13, 2023D90 Oltersdorf-
Dec 13, 2023D89 Wells And Clendon-
Dec 13, 2023D88 Arkin And Wells-
Dec 13, 2023D87 Wetterau 1998-
Dec 13, 2023D86 Benjannet-
Dec 13, 2023D85 Abstract Book Pcsk9 Conference Nantes ()-
Dec 13, 2023D84 Fraser 1995-
Dec 13, 2023D83 Wight And Merrilees-
Dec 13, 2023D82 Chan-
Dec 13, 2023D81 Prof. Boyd'S Chart From Us Proceedings-
Dec 13, 2023D80 Paul-
Dec 13, 2023D79 Dubuc-
Dec 13, 2023D78 Dunbar-
Dec 13, 2023D77 Brunzelle-
Dec 13, 2023D76 Hansen-
Dec 13, 2023D75 Blundell-
Dec 13, 2023D74 Blundell-
Dec 13, 2023D73 Manjasetty-
Dec 13, 2023D72 Mcpherson-
Dec 13, 2023D71 Ladner-
Dec 13, 2023D70 Sandin-
Dec 13, 2023Annex 1 Updated List Of Cited Documents Defendant Amgen-
Dec 13, 2023Acknowledgement Of Lodging-
Dec 13, 20232Nd Declaration Of Prof. A. Rees-
Dec 13, 20232Nd Declaration Of Dr. R. Parker-
Dec 5, 2023Amendpatentdefence-
Dec 5, 2023.11.13 Sanofi Cd Reply To Defence Signed-
Dec 4, 2023Receipt-
Dec 4, 2023Formal Checks Notification Of Positive Outcome-
Dec 4, 2023Defendant Amgens Application To Amend (Ar1 Ar17)-
Dec 4, 2023Auxiliary Requests Ar1 Ar17 (Marked Up Versions)-
Dec 4, 2023Auxiliary Requests Ar1 Ar17 (Clean Version)-
Dec 4, 2023Acknowledgement Of Lodging-
Dec 1, 2023Defendants Defence To Revocation (Includes Application To Amend)-
Dec 1, 2023Auxiliary Requests Ar1 17 (Marked Up Version)-
Dec 1, 2023Auxiliary Requests Ar1 17 (Clean Version)-
Nov 27, 2023Outcome Of The Order-
Nov 27, 2023Closing Workflow-
Nov 22, 2023Rop 9.3(A) Order-
Nov 22, 2023Receipt-
Nov 22, 2023Outcome Of The Order-
Nov 21, 2023Defandants Additional Comments Re Rule 9.3 Rop (Time Extension Request)-
Nov 20, 2023Response To Amgen Request 587598 For An Extension To Rejoinder-
Nov 20, 2023Preliminary Order Rop 9.3(A)-
Nov 17, 2023Response To Amgen Request 587598 For An Extension To Rejoinder-
Nov 17, 2023Receipt-
Nov 16, 2023Reasoned Request (Time Extension) Pursuant To Rule 9 Rop-
Nov 13, 2023E9 Signed-
Nov 13, 2023E8 Signed-
Nov 13, 2023E7 Signed-
Nov 13, 2023E10 Signed-
Nov 13, 2023C99 Signed-
Nov 13, 2023C98 Signed-
Nov 13, 2023C97 Signed-
Nov 13, 2023C96 Signed-
Nov 13, 2023C95 Signed-
Nov 13, 2023C94 Signed-
Nov 13, 2023C93 Signed-
Nov 13, 2023C92 Signed-
Nov 13, 2023C91 Signed-
Nov 13, 2023C90 Signed-
Nov 13, 2023C89 Signed-
Nov 13, 2023C88 Signed-
Nov 13, 2023C87 Signed-
Nov 13, 2023C86 Signed-
Nov 13, 2023C85 Signed-
Nov 13, 2023C84 Signed-
Nov 13, 2023C83 Signed-
Nov 13, 2023C82 Signed-
Nov 13, 2023C81 Signed-
Nov 13, 2023C80 Signed-
Nov 13, 2023C79 Signed-
Nov 13, 2023C78 Signed-
Nov 13, 2023C77 Signed-
Nov 13, 2023C76 Signed-
Nov 13, 2023C75 Signed-
Nov 13, 2023C74 Signed-
Nov 13, 2023C73 Signed-
Nov 13, 2023C72 Signed-
Nov 13, 2023C71 Signed-
Nov 13, 2023C70 Signed-
Nov 13, 2023C69 Signed-
Nov 13, 2023C68 Signed-
Nov 13, 2023C67 Signed-
Nov 13, 2023C66 Signed-
Nov 13, 2023C65 Signed-
Nov 13, 2023C64 Signed-
Nov 13, 2023C63 Signed-
Nov 13, 2023C62 Signed-
Nov 13, 2023C61 Signed-
Nov 13, 2023C60 Signed-
Nov 13, 2023C59 Signed-
Nov 13, 2023C58 Signed-
Nov 13, 2023C57 Signed-
Nov 13, 2023C56 Signed-
Nov 13, 2023C55 Signed-
Nov 13, 2023C54 Signed-
Nov 13, 2023C38A Signed-
Nov 13, 2023C111 Signed-
Nov 13, 2023C110 Signed-
Nov 13, 2023C109 Signed-
Nov 13, 2023C108 Signed-
Nov 13, 2023C107 Signed-
Nov 13, 2023C106 Signed-
Nov 13, 2023C105 Signed-
Nov 13, 2023C104 Signed-
Nov 13, 2023C103 Signed-
Nov 13, 2023C102 Signed-
Nov 13, 2023C101 Signed-
Nov 13, 2023C100 Signed-
Nov 13, 2023Acknowledgement Of Lodging-
Nov 13, 2023.11.13 Sanofi Cd Reply To Defence Signed-
Oct 16, 2023Order Rop 28 DATED 16 October-
Oct 16, 2023Official Date-
Oct 11, 2023Reply To Preliminary Order Setting Provisional Dates (Signed)-
Oct 9, 2023Defendants Reply To Po No. 577997 (No Objections)-
Oct 4, 2023Provisional Date-
Oct 4, 2023Preliminary Order Rule 28 Rop-
Sep 14, 2023Formal Checks Notification Of Positive Outcome-
Sep 14, 2023Acknowledgement Of Lodging-
Sep 12, 2023E6 Declaration Of Prof. T. Rees (With Cv)-
Sep 12, 2023E5 Declaration Of Dr R. Parker (With Cv)-
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part Iv-
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part Iii-
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part Ii-
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part I-
Sep 12, 2023Defendant Amgen'S Defence To Revocation-
Sep 12, 2023D9 CR OOKE-
Sep 12, 2023D8 Ni Et Al.-
Sep 12, 2023D7 Kruth-
Sep 12, 2023D6 Wo /057457 A2-
Sep 12, 2023D69 Examiner Notes About Irrelevance Of Tpos (March 27,)-
Sep 12, 2023D68 Examiner Interview Notes Re Tpos (March 15,)-
Sep 12, 2023D67 Examiner Interview Notes (March 1,)-
Sep 12, 2023D66 Bell-
Sep 12, 2023D65 Subramaniam-
Sep 12, 2023D64 Choi-
Sep 12, 2023D63 Spencer-
Sep 12, 2023D62 Novotny 1983-
Sep 12, 2023D61 Jia-
Sep 12, 2023D60 Soto-
Sep 12, 2023D5 Wo /043753 A2-
Sep 12, 2023D59 Hu-
Sep 12, 2023D58 Paull-
Sep 12, 2023D57 Nature Editorial-
Sep 12, 2023D56 Parameswaran And Liu-
Sep 12, 2023D55 Rudenko Full Validation Report-
Sep 12, 2023D54 Degenst-
Sep 12, 2023D53 Pedrioli And Oxenius-
Sep 12, 2023D52 Perelson Weisbuch 1995-
Sep 12, 2023D51 Raybould-
Sep 12, 2023D50 Edwards-
Sep 12, 2023D4 Kastelein-
Sep 12, 2023D49 Rudenko-
Sep 12, 2023D48 Baerga Ortiz-
Sep 12, 2023D47 Glaser 1992-
Sep 12, 2023D46 Maccallum 1996-
Sep 12, 2023D45 Ye-
Sep 12, 2023D44 Chowdhury 1999-
Sep 12, 2023D43 Roberts 1987-
Sep 12, 2023D42 Us 8,357,371 B2-
Sep 12, 2023D41 EP2358756B1-
Sep 12, 2023D40 Declaration Of Wei Wang-
Sep 12, 2023D40B Appendix B Wang Lab Notebook-
Sep 12, 2023D40A Appendix A Wang Lab Notebook-
Sep 12, 2023D3 Frank Kamenetsky Et Al.-
Sep 12, 2023D39 Declaration Of Kelly Berry-
Sep 12, 2023D38 Kondrashov-
Sep 12, 2023D37 Rees-
Sep 12, 2023D36 Baran-
Sep 12, 2023D35 Lo Surdo-
Sep 12, 2023D34 Eliassen-
Sep 12, 2023D33 Esteve-
Sep 12, 2023D32 Mitchell-
Sep 12, 2023D31 Us 8,420,098 B2-
Sep 12, 2023D30 Horton-
Sep 12, 2023D2 Us 7,737,266 B2 (Alnylam)-
Sep 12, 2023D29 Wo /1057797-
Sep 12, 2023D28 Press Release Bms Isis-
Sep 12, 2023D27 Poirier-
Sep 12, 2023D26 Poirier-
Sep 12, 2023D25 Mcnutt-
Sep 12, 2023D24 Us /0275053-
Sep 12, 2023D23 Grefhorst-
Sep 12, 2023D22 Ioannidis-
Sep 12, 2023D21 Homer-
Sep 12, 2023D20 Nassoury-
Sep 12, 2023D1 Seeking Alpha Alnylam-
Sep 12, 2023D19 Graham-
Sep 12, 2023D18 Seidah-
Sep 12, 2023D17 Maxwell-
Sep 12, 2023D16 Horton-
Sep 12, 2023D15 Lagace Supplemental Data To C3-
Sep 12, 2023D14 Havel And Hamilton-
Sep 12, 2023D13 Mccuskey-
Sep 12, 2023D12 Brown And Goldstein 1979-
Sep 12, 2023D11 Brown And Goldstein 1986-
Sep 12, 2023D10 Bell-
Sep 12, 2023Ar1 Ar17 (Marked Up)-
Sep 12, 2023Ar1 Ar17 (Clean Version)-
Sep 12, 2023Annex 2 Aso Technology-
Sep 12, 2023Annex 1 List Of Cited Documents Defendant Amgen-
Aug 24, 2023Preliminary Objection Decisionoutcome-
Aug 24, 2023Order Rejecting Preliminary Objection DATED 24 August-
Aug 23, 2023554674/Oh/2Mu/Upc202308173Pm-
Aug 21, 2023Outcome Of The Order-
Aug 21, 2023Order Re 9.3(A) Request Granting 2 Weeks Extension-
Aug 21, 2023Comments Pursuant To Rop264-
Aug 18, 2023Outcome Of The Order-
Aug 18, 2023Order Closing Application-
Aug 17, 2023Re Rule 9.3(A) Request Closing This Application-
Aug 17, 2023Receipt-
Aug 17, 2023Preliminary Order 17 August Rule 9 Application-
Aug 17, 2023Outcome Of The Order-
Aug 17, 2023Letter Adding Co Representatives 17 Aug (Signed)-
Aug 16, 2023Supplementary Submission To Extension Request-
Aug 16, 2023Public Attendance Order Hearing-
Aug 16, 2023Order Re Public Attendance Po Hearing (Ord 562392 2023)-
Aug 16, 2023Order Re Public Attendance Po Hearing-
Aug 16, 2023Application-
Aug 15, 2023Submission In Reply To Claimants Response To Preliminary Objection (Rule 49.1 Rop)-
Aug 15, 2023Reasoned Request Pursuant To Rule 9 Rop-
Aug 9, 2023Hearing Invitation 17 August 1500-
Aug 9, 2023Hearing Dates-
Aug 8, 2023Exhibit CR PO 6B Signed-
Aug 8, 2023Exhibit CR PO 6A Signed-
Aug 8, 2023Exhibit CR PO 5B Signed-
Aug 8, 2023Exhibit CR PO 5A Signed-
Aug 8, 2023Exhibit CR PO 4B Signed-
Aug 8, 2023Exhibit CR PO 4A Signed-
Aug 8, 2023Exhibit CR PO 3 Signed-
Aug 8, 2023Exhibit CR PO 2 Signed-
Aug 8, 2023Exhibit CR PO 1 Signed-
Aug 8, 2023Commentpreliminaryobjection-
Aug 8, 2023Comment On Preliminary Objection-
Aug 8, 2023Annex To Exhibit CR PO 2 Signed-
Aug 4, 2023Template Order-
Jul 31, 2023Receipt-
Jul 28, 2023.07.28 Withdrawal Of Document Request Action No 459505 Signed Agc-
Jul 25, 2023Preliminary Objection Of Defendant (R. 48 And R. 19.1 Rop)-
Jul 25, 2023Preliminaryobjection-
Jul 25, 2023Formal Checks Request For Correction-
Jul 25, 2023Exhibit Ed 2-
Jul 25, 2023Exhibit Ed 1-
Jul 21, 2023Preliminary Objection According To R. 48 And R 19.1 Rop-
Jul 21, 2023Exhibit Ed2-
Jul 21, 2023Exhibit Ed1-
Jul 17, 2023Formal Checks Request For Correction-
Jul 12, 2023Reply Of Defendant (Amgen) To Intended Appointment Of Tqj-
Jul 12, 2023Acknowledgement Of Lodging-
Jul 5, 2023Acknowledgement Of Adding A Missing Party Or Applicant-
Jun 29, 2023Upc Cfi 1 Formal Response To The Procedural Order Of The Court 536514 2023 Dated Signed-
Jun 29, 2023Outcome Of The Order-
Jun 29, 2023Order Generic Application-
Jun 29, 2023Acknowledgement Of Access To Case-
Jun 27, 2023Receipt-
Jun 23, 2023Rule 9 Order Final-
Jun 23, 2023Payment Receipt Signed-
Jun 23, 2023P4B 61 086133 Signed-
Jun 23, 2023P4A 61 086133 Signed-
Jun 23, 2023P3G 61 010630 Signed-
Jun 23, 2023P3F 61 010630 Signed-
Jun 23, 2023P3E 61 010630 Signed-
Jun 23, 2023P3D 61 010630 Signed-
Jun 23, 2023P3C 61 010630 Signed-
Jun 23, 2023P3B 61 010630 Signed-
Jun 23, 2023P3A 61 010630 Signed-
Jun 23, 2023P2B 61 008965 Signed-
Jun 23, 2023P2A 61 008965 Signed-
Jun 23, 2023P1 60 957668 Signed-
Jun 23, 2023Notification Of Service-
Jun 23, 2023Letter For Service-
Jun 23, 2023E4 Zwicker Declaration Signed-
Jun 23, 2023E3 Boyd Declaration Cv Signed-
Jun 23, 2023E2 Horton Declaration Cv Signed-
Jun 23, 2023E1 Schwartz Declaration Citations Signed-
Jun 23, 2023C9 Mcnutt Signed-
Jun 23, 2023C8 Cunningham Signed-
Jun 23, 2023C7 Fisher Signed-
Jun 23, 2023C6 Qian Signed-
Jun 23, 2023C5 Kwon Signed-
Jun 23, 2023C53 European Patent Register For .4 Signed-
Jun 23, 2023C52 National Register Extracts Signed-
Jun 23, 2023C51 Maggon Signed-
Jun 23, 2023C50 Weiner Signed-
Jun 23, 2023C4 Zhang Signed-
Jun 23, 2023C49 Wo 077854 Signed-
Jun 23, 2023C49A US61 168753 Signed-
Jun 23, 2023C48 Duff Signed-
Jun 23, 2023C47 Glennie And Johnson Signed-
Jun 23, 2023C46 Hoogenboom And Chames Signed-
Jun 23, 2023C45 Claims Filed In November And Sections Of Response Signed-
Jun 23, 2023C44 Claims Filed With Response To Eesr And Sections Of Response Signed-
Jun 23, 2023C43 Claims And Accompanying Letter Feb Signed-
Jun 23, 2023C42 Zhao Signed-
Jun 23, 2023C41 Kuroda Signed-
Jun 23, 2023C40 Summary Of European National Case Law On Sufficiency Of Disclosure Signed-
Jun 23, 2023C3 Lagace Signed-
Jun 23, 2023C39 Brown Goldstein Signed-
Jun 23, 2023C38 WO2009055783 Signed-
Jun 23, 2023C37B WO2008105797 Signed-
Jun 23, 2023C37A WO2008105797 Signed-
Jun 23, 2023C36 Seidah Signed-
Jun 23, 2023C35 Goldstein Brown 1975 Signed-
Jun 23, 2023C34D Turk Signed-
Jun 23, 2023C34C Turk Signed-
Jun 23, 2023C34B Turk Signed-
Jun 23, 2023C34A Turk Signed-
Jun 23, 2023C33 Benjannet Signed-
Jun 23, 2023C32 Park Signed-
Jun 23, 2023C31B Sun Signed-
Jun 23, 2023C31A Sun Signed-
Jun 23, 2023C30 Berge Signed-
Jun 23, 2023C2 Wo 100318 Signed-
Jun 23, 2023C2C Gao Signed-
Jun 23, 2023C2B Pct Request For C2 Signed-
Jun 23, 2023C2A US61 063980 Signed-
Jun 23, 2023C29 Abifadel Signed-
Jun 23, 2023C28 Cohen Signed-
Jun 23, 2023C27 Maxwell Signed-
Jun 23, 2023C26 Holla Signed-
Jun 23, 2023C25 Rashid Signed-
Jun 23, 2023C24B Hoogenboom Signed-
Jun 23, 2023C24A Hoogenboom Signed-
Jun 23, 2023C23 Antibody Engineering Methods And Protocols Signed-
Jun 23, 2023C22 Phage Display A Laboratory Manual Signed-
Jun 23, 2023C21 Cameron Signed-
Jun 23, 2023C20 Bottomley Signed-
Jun 23, 2023C1 Wo 100297 Signed-
Jun 23, 2023C1F Ni Signed-
Jun 23, 2023C1E Wikipedia Simvastatin Signed-
Jun 23, 2023C1D Preliminary Opinion Of The Enlarged Board In G1 22 And G2 22 Signed-
Jun 23, 2023C1C Pct Request For C1 Signed-
Jun 23, 2023C1B US61 066577 Signed-
Jun 23, 2023C1A US61 063949 Signed-
Jun 23, 2023C19 Ramasamy Signed-
Jun 23, 2023C18 Sarkar Et Al Signed-
Jun 23, 2023C17 Seidah And Prat Signed-
Jun 23, 2023C16 Cohen Signed-
Jun 23, 2023C15 Seidah Signed-
Jun 23, 2023C14 Lopez Signed-
Jun 23, 2023C13 Hampton Signed-
Jun 23, 2023C12 Piper Signed-
Jun 23, 2023C11 Horton Signed-
Jun 23, 2023C10 Wo 125623 Signed-
Jun 23, 2023B1V EP3666797 Signed-
Jun 23, 2023B1U EP3666797 Signed-
Jun 23, 2023B1T EP3666797 Signed-
Jun 23, 2023B1S EP3666797 Signed-
Jun 23, 2023B1R EP3666797 Signed-
Jun 23, 2023B1Q EP3666797 Signed-
Jun 23, 2023B1P EP3666797 Signed-
Jun 23, 2023B1O EP3666797 Signed-
Jun 23, 2023B1N EP3666797 Signed-
Jun 23, 2023B1M EP3666797 Signed-
Jun 23, 2023B1L EP3666797 Signed-
Jun 23, 2023B1K EP3666797 Signed-
Jun 23, 2023B1J EP3666797 Signed-
Jun 23, 2023B1I EP3666797 Signed-
Jun 23, 2023B1H EP3666797 Signed-
Jun 23, 2023B1G EP3666797 Signed-
Jun 23, 2023B1F EP3666797 Signed-
Jun 23, 2023B1E EP3666797 Signed-
Jun 23, 2023B1D EP3666797 Signed-
Jun 23, 2023B1C EP3666797 Signed-
Jun 23, 2023B1B EP3666797 Signed-
Jun 23, 2023B1A EP3666797 Signed-
Jun 23, 2023A1F Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1E Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1D Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1C Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1B Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1A Wo 026558 Pct Application As Filed Signed-
Jun 20, 2023Panel Appointment-
Jun 2, 2023Statementofrevocation-
Jun 2, 2023Formal Checks Notification Of Positive Outcome-
Jun 1, 2023Sanofi V Amgen Revocation Action EP3666797 Signed V2-
Jun 1, 2023Letter To Registry Sanofi V Amgen Uploading Issues On Signed-
Jun 1, 2023.06.01 Letter To The Upc Lodging Of Revocation Action-
Oct 23, 2024Procedural Order App 47172-
Oct 23, 2024Procedural Order App 47163-
Jul 16, 2024Final Order Anonymised-
Jul 16, 2024Decision Revocation Action 1
Jul 16, 2024Decisionoutcome-
Jul 4, 2024Announcement
Jun 5, 2024Oral Hearing Referencing 459505-
May 22, 2024Interimprocedureclosure-
May 13, 2024Receipt-
May 10, 2024Amgen Slides-
May 10, 2024Amgen R 9 Appl Filing Slides-
May 10, 2024.05.10 Sanofi And Regeneron Slides Signed-
May 10, 2024.05.10 Sanofi And Regeneron Slide Reference Table Signed-
May 10, 2024.05.10 Cover Letter Accompanying Slides Signed-
May 7, 2024Receipt-
May 7, 2024Outcome Of The Order-
May 7, 2024Order Re Admission Of Documents
May 7, 2024Extension Order Slides
May 6, 2024Extension Request-
May 3, 2024Amgen Reply To Prel Order 30 April-
Apr 30, 2024Po-
Apr 30, 2024Outcome Of The Order-
Apr 30, 2024Order Closing Workflow-
Apr 26, 2024Receipt-
Apr 26, 2024C54A Amgen Infringement Claim (En Translation)-
Apr 26, 2024C37A US60 818234 (Priority Document To Bms Patent Application) (Signed)-
Apr 26, 2024Annex 1 Updated Consolidated List Of Exhibits And Evidence (Signed)-
Apr 26, 2024.04.26 Rop 9.1 Application Re C37A (Signed)-
Apr 19, 2024Writtenprocedureclosure-
Apr 19, 2024Summons Oral Hearing
Apr 19, 2024Summons-
Apr 19, 2024Hearing Dates-
Apr 5, 2024Receipt-
Apr 5, 2024Case Summary-
Apr 5, 2024Annex 2 Notice Of Experts (Signed)-
Apr 5, 2024Annex 1 CR OSS Reference Table (Signed)-
Apr 5, 2024Amgen Response Cd To Sanofi Submission Re Pan Declaration-
Apr 5, 2024Amgen Cover Letter Case Summary-
Apr 5, 2024.04.05 Claimants Case Summary Signed-
Apr 5, 2024.03.07 Reply To Amgen Defence To The Counterclaim For Invalidity (Signed)-
Mar 7, 2024.03.07 Reply To Amgen Defence To The Counterclaim For Invalidity (Signed)-
Mar 4, 2024Order To Combine Cases Act 459505 And Cc 586764-
Feb 27, 2024Order To Combine Cases-
Feb 6, 2024Receipt-
Feb 5, 2024Order Local Division 2 February-
Feb 5, 2024Exhibit-
Feb 5, 2024D99 Edrees Et Al-
Feb 5, 2024C10A Priority Document-
Feb 5, 2024Application For A Procedural Order Pursuant To Rule 9(1) Rop-
Feb 5, 2024Application-
Jan 24, 2024Rop 9.1 Order Final-
Jan 24, 2024Outcome Of The Order-
Jan 19, 2024Amgen Response Cd Order Rule 9 Application-
Jan 17, 2024Representation-
Jan 16, 2024Template Order-
Jan 16, 2024Receipt-
Jan 16, 2024Preliminary Order 16 January Rop 9-
Jan 16, 2024Acknowledgement Of Change Of A Representative-
Jan 15, 2024Rejoinder To Reply To Defence To Application To Amend-
Jan 15, 2024Rejoinamendpatentdefence-
Jan 15, 2024Exhibit E15-
Jan 15, 2024Exhibit E14-
Jan 15, 2024Exhibit E13-
Jan 15, 2024Exhibit C114-
Jan 15, 2024Exhibit C113-
Jan 15, 2024Exhibit C112-
Jan 15, 2024Application-
Jan 9, 2024Formal Checks Notification Of Positive Outcome-
Jan 9, 2024App R293 Receipt-
Dec 22, 2023Explanations Re Application For Change Of Representative (R. 293 Rop)-
Dec 22, 2023Acknowledgement Of Lodging-
Dec 13, 2023Replyamendpatentdefence-
Dec 13, 2023Defendants Reply To Claimants Defence To Application To Amend-
Dec 13, 2023Defendants Rejoinder To Reply To Defence (13.12.)-
Dec 13, 2023D98 Internal Amgen Research Document ()-
Dec 13, 2023D97 Transcript Of Feb 22, Trial Hearing (S. Jackson)-
Dec 13, 2023D96 Mgi Mouse Facts-
Dec 13, 2023D95 Horton Parker Joint Expert Report-
Dec 13, 2023D94 Weider-
Dec 13, 2023D93 O. Pan Declaration-
Dec 13, 2023D92 US8710192B2 (Novartis)-
Dec 13, 2023D91 Lin-
Dec 13, 2023D90 Oltersdorf-
Dec 13, 2023D89 Wells And Clendon-
Dec 13, 2023D88 Arkin And Wells-
Dec 13, 2023D87 Wetterau 1998-
Dec 13, 2023D86 Benjannet-
Dec 13, 2023D85 Abstract Book Pcsk9 Conference Nantes ()-
Dec 13, 2023D84 Fraser 1995-
Dec 13, 2023D83 Wight And Merrilees-
Dec 13, 2023D82 Chan-
Dec 13, 2023D81 Prof. Boyd'S Chart From Us Proceedings-
Dec 13, 2023D80 Paul-
Dec 13, 2023D79 Dubuc-
Dec 13, 2023D78 Dunbar-
Dec 13, 2023D77 Brunzelle-
Dec 13, 2023D76 Hansen-
Dec 13, 2023D75 Blundell-
Dec 13, 2023D74 Blundell-
Dec 13, 2023D73 Manjasetty-
Dec 13, 2023D72 Mcpherson-
Dec 13, 2023D71 Ladner-
Dec 13, 2023D70 Sandin-
Dec 13, 2023Annex 1 Updated List Of Cited Documents Defendant Amgen-
Dec 13, 2023Acknowledgement Of Lodging-
Dec 13, 20232Nd Declaration Of Prof. A. Rees-
Dec 13, 20232Nd Declaration Of Dr. R. Parker-
Dec 5, 2023Amendpatentdefence-
Dec 5, 2023.11.13 Sanofi Cd Reply To Defence Signed-
Dec 4, 2023Receipt-
Dec 4, 2023Formal Checks Notification Of Positive Outcome-
Dec 4, 2023Defendant Amgens Application To Amend (Ar1 Ar17)-
Dec 4, 2023Auxiliary Requests Ar1 Ar17 (Marked Up Versions)-
Dec 4, 2023Auxiliary Requests Ar1 Ar17 (Clean Version)-
Dec 4, 2023Acknowledgement Of Lodging-
Dec 1, 2023Defendants Defence To Revocation (Includes Application To Amend)-
Dec 1, 2023Auxiliary Requests Ar1 17 (Marked Up Version)-
Dec 1, 2023Auxiliary Requests Ar1 17 (Clean Version)-
Nov 27, 2023Outcome Of The Order-
Nov 27, 2023Closing Workflow-
Nov 22, 2023Rop 9.3(A) Order-
Nov 22, 2023Receipt-
Nov 22, 2023Outcome Of The Order-
Nov 21, 2023Defandants Additional Comments Re Rule 9.3 Rop (Time Extension Request)-
Nov 20, 2023Response To Amgen Request 587598 For An Extension To Rejoinder-
Nov 20, 2023Preliminary Order Rop 9.3(A)-
Nov 17, 2023Response To Amgen Request 587598 For An Extension To Rejoinder-
Nov 17, 2023Receipt-
Nov 16, 2023Reasoned Request (Time Extension) Pursuant To Rule 9 Rop-
Nov 13, 2023E9 Signed-
Nov 13, 2023E8 Signed-
Nov 13, 2023E7 Signed-
Nov 13, 2023E10 Signed-
Nov 13, 2023C99 Signed-
Nov 13, 2023C98 Signed-
Nov 13, 2023C97 Signed-
Nov 13, 2023C96 Signed-
Nov 13, 2023C95 Signed-
Nov 13, 2023C94 Signed-
Nov 13, 2023C93 Signed-
Nov 13, 2023C92 Signed-
Nov 13, 2023C91 Signed-
Nov 13, 2023C90 Signed-
Nov 13, 2023C89 Signed-
Nov 13, 2023C88 Signed-
Nov 13, 2023C87 Signed-
Nov 13, 2023C86 Signed-
Nov 13, 2023C85 Signed-
Nov 13, 2023C84 Signed-
Nov 13, 2023C83 Signed-
Nov 13, 2023C82 Signed-
Nov 13, 2023C81 Signed-
Nov 13, 2023C80 Signed-
Nov 13, 2023C79 Signed-
Nov 13, 2023C78 Signed-
Nov 13, 2023C77 Signed-
Nov 13, 2023C76 Signed-
Nov 13, 2023C75 Signed-
Nov 13, 2023C74 Signed-
Nov 13, 2023C73 Signed-
Nov 13, 2023C72 Signed-
Nov 13, 2023C71 Signed-
Nov 13, 2023C70 Signed-
Nov 13, 2023C69 Signed-
Nov 13, 2023C68 Signed-
Nov 13, 2023C67 Signed-
Nov 13, 2023C66 Signed-
Nov 13, 2023C65 Signed-
Nov 13, 2023C64 Signed-
Nov 13, 2023C63 Signed-
Nov 13, 2023C62 Signed-
Nov 13, 2023C61 Signed-
Nov 13, 2023C60 Signed-
Nov 13, 2023C59 Signed-
Nov 13, 2023C58 Signed-
Nov 13, 2023C57 Signed-
Nov 13, 2023C56 Signed-
Nov 13, 2023C55 Signed-
Nov 13, 2023C54 Signed-
Nov 13, 2023C38A Signed-
Nov 13, 2023C111 Signed-
Nov 13, 2023C110 Signed-
Nov 13, 2023C109 Signed-
Nov 13, 2023C108 Signed-
Nov 13, 2023C107 Signed-
Nov 13, 2023C106 Signed-
Nov 13, 2023C105 Signed-
Nov 13, 2023C104 Signed-
Nov 13, 2023C103 Signed-
Nov 13, 2023C102 Signed-
Nov 13, 2023C101 Signed-
Nov 13, 2023C100 Signed-
Nov 13, 2023Acknowledgement Of Lodging-
Nov 13, 2023.11.13 Sanofi Cd Reply To Defence Signed-
Oct 16, 2023Order Rop 28 DATED 16 October-
Oct 16, 2023Official Date-
Oct 11, 2023Reply To Preliminary Order Setting Provisional Dates (Signed)-
Oct 9, 2023Defendants Reply To Po No. 577997 (No Objections)-
Oct 4, 2023Provisional Date-
Oct 4, 2023Preliminary Order Rule 28 Rop-
Sep 14, 2023Formal Checks Notification Of Positive Outcome-
Sep 14, 2023Acknowledgement Of Lodging-
Sep 12, 2023E6 Declaration Of Prof. T. Rees (With Cv)-
Sep 12, 2023E5 Declaration Of Dr R. Parker (With Cv)-
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part Iv-
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part Iii-
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part Ii-
Sep 12, 2023Divisional Application As Filed (Oa) EP3666797A1 Part I-
Sep 12, 2023Defendant Amgen'S Defence To Revocation-
Sep 12, 2023D9 CR OOKE-
Sep 12, 2023D8 Ni Et Al.-
Sep 12, 2023D7 Kruth-
Sep 12, 2023D6 Wo /057457 A2-
Sep 12, 2023D69 Examiner Notes About Irrelevance Of Tpos (March 27,)-
Sep 12, 2023D68 Examiner Interview Notes Re Tpos (March 15,)-
Sep 12, 2023D67 Examiner Interview Notes (March 1,)-
Sep 12, 2023D66 Bell-
Sep 12, 2023D65 Subramaniam-
Sep 12, 2023D64 Choi-
Sep 12, 2023D63 Spencer-
Sep 12, 2023D62 Novotny 1983-
Sep 12, 2023D61 Jia-
Sep 12, 2023D60 Soto-
Sep 12, 2023D5 Wo /043753 A2-
Sep 12, 2023D59 Hu-
Sep 12, 2023D58 Paull-
Sep 12, 2023D57 Nature Editorial-
Sep 12, 2023D56 Parameswaran And Liu-
Sep 12, 2023D55 Rudenko Full Validation Report-
Sep 12, 2023D54 Degenst-
Sep 12, 2023D53 Pedrioli And Oxenius-
Sep 12, 2023D52 Perelson Weisbuch 1995-
Sep 12, 2023D51 Raybould-
Sep 12, 2023D50 Edwards-
Sep 12, 2023D4 Kastelein-
Sep 12, 2023D49 Rudenko-
Sep 12, 2023D48 Baerga Ortiz-
Sep 12, 2023D47 Glaser 1992-
Sep 12, 2023D46 Maccallum 1996-
Sep 12, 2023D45 Ye-
Sep 12, 2023D44 Chowdhury 1999-
Sep 12, 2023D43 Roberts 1987-
Sep 12, 2023D42 Us 8,357,371 B2-
Sep 12, 2023D41 EP2358756B1-
Sep 12, 2023D40 Declaration Of Wei Wang-
Sep 12, 2023D40B Appendix B Wang Lab Notebook-
Sep 12, 2023D40A Appendix A Wang Lab Notebook-
Sep 12, 2023D3 Frank Kamenetsky Et Al.-
Sep 12, 2023D39 Declaration Of Kelly Berry-
Sep 12, 2023D38 Kondrashov-
Sep 12, 2023D37 Rees-
Sep 12, 2023D36 Baran-
Sep 12, 2023D35 Lo Surdo-
Sep 12, 2023D34 Eliassen-
Sep 12, 2023D33 Esteve-
Sep 12, 2023D32 Mitchell-
Sep 12, 2023D31 Us 8,420,098 B2-
Sep 12, 2023D30 Horton-
Sep 12, 2023D2 Us 7,737,266 B2 (Alnylam)-
Sep 12, 2023D29 Wo /1057797-
Sep 12, 2023D28 Press Release Bms Isis-
Sep 12, 2023D27 Poirier-
Sep 12, 2023D26 Poirier-
Sep 12, 2023D25 Mcnutt-
Sep 12, 2023D24 Us /0275053-
Sep 12, 2023D23 Grefhorst-
Sep 12, 2023D22 Ioannidis-
Sep 12, 2023D21 Homer-
Sep 12, 2023D20 Nassoury-
Sep 12, 2023D1 Seeking Alpha Alnylam-
Sep 12, 2023D19 Graham-
Sep 12, 2023D18 Seidah-
Sep 12, 2023D17 Maxwell-
Sep 12, 2023D16 Horton-
Sep 12, 2023D15 Lagace Supplemental Data To C3-
Sep 12, 2023D14 Havel And Hamilton-
Sep 12, 2023D13 Mccuskey-
Sep 12, 2023D12 Brown And Goldstein 1979-
Sep 12, 2023D11 Brown And Goldstein 1986-
Sep 12, 2023D10 Bell-
Sep 12, 2023Ar1 Ar17 (Marked Up)-
Sep 12, 2023Ar1 Ar17 (Clean Version)-
Sep 12, 2023Annex 2 Aso Technology-
Sep 12, 2023Annex 1 List Of Cited Documents Defendant Amgen-
Aug 24, 2023Preliminary Objection Decisionoutcome-
Aug 24, 2023Order Rejecting Preliminary Objection DATED 24 August-
Aug 23, 2023554674/Oh/2Mu/Upc202308173Pm-
Aug 21, 2023Outcome Of The Order-
Aug 21, 2023Order Re 9.3(A) Request Granting 2 Weeks Extension-
Aug 21, 2023Comments Pursuant To Rop264-
Aug 18, 2023Outcome Of The Order-
Aug 18, 2023Order Closing Application-
Aug 17, 2023Re Rule 9.3(A) Request Closing This Application-
Aug 17, 2023Receipt-
Aug 17, 2023Preliminary Order 17 August Rule 9 Application-
Aug 17, 2023Outcome Of The Order-
Aug 17, 2023Letter Adding Co Representatives 17 Aug (Signed)-
Aug 16, 2023Supplementary Submission To Extension Request-
Aug 16, 2023Public Attendance Order Hearing-
Aug 16, 2023Order Re Public Attendance Po Hearing (Ord 562392 2023)-
Aug 16, 2023Order Re Public Attendance Po Hearing-
Aug 16, 2023Application-
Aug 15, 2023Submission In Reply To Claimants Response To Preliminary Objection (Rule 49.1 Rop)-
Aug 15, 2023Reasoned Request Pursuant To Rule 9 Rop-
Aug 9, 2023Hearing Invitation 17 August 1500-
Aug 9, 2023Hearing Dates-
Aug 8, 2023Exhibit CR PO 6B Signed-
Aug 8, 2023Exhibit CR PO 6A Signed-
Aug 8, 2023Exhibit CR PO 5B Signed-
Aug 8, 2023Exhibit CR PO 5A Signed-
Aug 8, 2023Exhibit CR PO 4B Signed-
Aug 8, 2023Exhibit CR PO 4A Signed-
Aug 8, 2023Exhibit CR PO 3 Signed-
Aug 8, 2023Exhibit CR PO 2 Signed-
Aug 8, 2023Exhibit CR PO 1 Signed-
Aug 8, 2023Commentpreliminaryobjection-
Aug 8, 2023Comment On Preliminary Objection-
Aug 8, 2023Annex To Exhibit CR PO 2 Signed-
Aug 4, 2023Template Order-
Jul 31, 2023Receipt-
Jul 28, 2023.07.28 Withdrawal Of Document Request Action No 459505 Signed Agc-
Jul 25, 2023Preliminary Objection Of Defendant (R. 48 And R. 19.1 Rop)-
Jul 25, 2023Preliminaryobjection-
Jul 25, 2023Formal Checks Request For Correction-
Jul 25, 2023Exhibit Ed 2-
Jul 25, 2023Exhibit Ed 1-
Jul 21, 2023Preliminary Objection According To R. 48 And R 19.1 Rop-
Jul 21, 2023Exhibit Ed2-
Jul 21, 2023Exhibit Ed1-
Jul 17, 2023Formal Checks Request For Correction-
Jul 12, 2023Reply Of Defendant (Amgen) To Intended Appointment Of Tqj-
Jul 12, 2023Acknowledgement Of Lodging-
Jul 5, 2023Acknowledgement Of Adding A Missing Party Or Applicant-
Jun 29, 2023Upc Cfi 1 Formal Response To The Procedural Order Of The Court 536514 2023 Dated Signed-
Jun 29, 2023Outcome Of The Order-
Jun 29, 2023Order Generic Application-
Jun 29, 2023Acknowledgement Of Access To Case-
Jun 27, 2023Receipt-
Jun 23, 2023Rule 9 Order Final-
Jun 23, 2023Payment Receipt Signed-
Jun 23, 2023P4B 61 086133 Signed-
Jun 23, 2023P4A 61 086133 Signed-
Jun 23, 2023P3G 61 010630 Signed-
Jun 23, 2023P3F 61 010630 Signed-
Jun 23, 2023P3E 61 010630 Signed-
Jun 23, 2023P3D 61 010630 Signed-
Jun 23, 2023P3C 61 010630 Signed-
Jun 23, 2023P3B 61 010630 Signed-
Jun 23, 2023P3A 61 010630 Signed-
Jun 23, 2023P2B 61 008965 Signed-
Jun 23, 2023P2A 61 008965 Signed-
Jun 23, 2023P1 60 957668 Signed-
Jun 23, 2023Notification Of Service-
Jun 23, 2023Letter For Service-
Jun 23, 2023E4 Zwicker Declaration Signed-
Jun 23, 2023E3 Boyd Declaration Cv Signed-
Jun 23, 2023E2 Horton Declaration Cv Signed-
Jun 23, 2023E1 Schwartz Declaration Citations Signed-
Jun 23, 2023C9 Mcnutt Signed-
Jun 23, 2023C8 Cunningham Signed-
Jun 23, 2023C7 Fisher Signed-
Jun 23, 2023C6 Qian Signed-
Jun 23, 2023C5 Kwon Signed-
Jun 23, 2023C53 European Patent Register For .4 Signed-
Jun 23, 2023C52 National Register Extracts Signed-
Jun 23, 2023C51 Maggon Signed-
Jun 23, 2023C50 Weiner Signed-
Jun 23, 2023C4 Zhang Signed-
Jun 23, 2023C49 Wo 077854 Signed-
Jun 23, 2023C49A US61 168753 Signed-
Jun 23, 2023C48 Duff Signed-
Jun 23, 2023C47 Glennie And Johnson Signed-
Jun 23, 2023C46 Hoogenboom And Chames Signed-
Jun 23, 2023C45 Claims Filed In November And Sections Of Response Signed-
Jun 23, 2023C44 Claims Filed With Response To Eesr And Sections Of Response Signed-
Jun 23, 2023C43 Claims And Accompanying Letter Feb Signed-
Jun 23, 2023C42 Zhao Signed-
Jun 23, 2023C41 Kuroda Signed-
Jun 23, 2023C40 Summary Of European National Case Law On Sufficiency Of Disclosure Signed-
Jun 23, 2023C3 Lagace Signed-
Jun 23, 2023C39 Brown Goldstein Signed-
Jun 23, 2023C38 WO2009055783 Signed-
Jun 23, 2023C37B WO2008105797 Signed-
Jun 23, 2023C37A WO2008105797 Signed-
Jun 23, 2023C36 Seidah Signed-
Jun 23, 2023C35 Goldstein Brown 1975 Signed-
Jun 23, 2023C34D Turk Signed-
Jun 23, 2023C34C Turk Signed-
Jun 23, 2023C34B Turk Signed-
Jun 23, 2023C34A Turk Signed-
Jun 23, 2023C33 Benjannet Signed-
Jun 23, 2023C32 Park Signed-
Jun 23, 2023C31B Sun Signed-
Jun 23, 2023C31A Sun Signed-
Jun 23, 2023C30 Berge Signed-
Jun 23, 2023C2 Wo 100318 Signed-
Jun 23, 2023C2C Gao Signed-
Jun 23, 2023C2B Pct Request For C2 Signed-
Jun 23, 2023C2A US61 063980 Signed-
Jun 23, 2023C29 Abifadel Signed-
Jun 23, 2023C28 Cohen Signed-
Jun 23, 2023C27 Maxwell Signed-
Jun 23, 2023C26 Holla Signed-
Jun 23, 2023C25 Rashid Signed-
Jun 23, 2023C24B Hoogenboom Signed-
Jun 23, 2023C24A Hoogenboom Signed-
Jun 23, 2023C23 Antibody Engineering Methods And Protocols Signed-
Jun 23, 2023C22 Phage Display A Laboratory Manual Signed-
Jun 23, 2023C21 Cameron Signed-
Jun 23, 2023C20 Bottomley Signed-
Jun 23, 2023C1 Wo 100297 Signed-
Jun 23, 2023C1F Ni Signed-
Jun 23, 2023C1E Wikipedia Simvastatin Signed-
Jun 23, 2023C1D Preliminary Opinion Of The Enlarged Board In G1 22 And G2 22 Signed-
Jun 23, 2023C1C Pct Request For C1 Signed-
Jun 23, 2023C1B US61 066577 Signed-
Jun 23, 2023C1A US61 063949 Signed-
Jun 23, 2023C19 Ramasamy Signed-
Jun 23, 2023C18 Sarkar Et Al Signed-
Jun 23, 2023C17 Seidah And Prat Signed-
Jun 23, 2023C16 Cohen Signed-
Jun 23, 2023C15 Seidah Signed-
Jun 23, 2023C14 Lopez Signed-
Jun 23, 2023C13 Hampton Signed-
Jun 23, 2023C12 Piper Signed-
Jun 23, 2023C11 Horton Signed-
Jun 23, 2023C10 Wo 125623 Signed-
Jun 23, 2023B1V EP3666797 Signed-
Jun 23, 2023B1U EP3666797 Signed-
Jun 23, 2023B1T EP3666797 Signed-
Jun 23, 2023B1S EP3666797 Signed-
Jun 23, 2023B1R EP3666797 Signed-
Jun 23, 2023B1Q EP3666797 Signed-
Jun 23, 2023B1P EP3666797 Signed-
Jun 23, 2023B1O EP3666797 Signed-
Jun 23, 2023B1N EP3666797 Signed-
Jun 23, 2023B1M EP3666797 Signed-
Jun 23, 2023B1L EP3666797 Signed-
Jun 23, 2023B1K EP3666797 Signed-
Jun 23, 2023B1J EP3666797 Signed-
Jun 23, 2023B1I EP3666797 Signed-
Jun 23, 2023B1H EP3666797 Signed-
Jun 23, 2023B1G EP3666797 Signed-
Jun 23, 2023B1F EP3666797 Signed-
Jun 23, 2023B1E EP3666797 Signed-
Jun 23, 2023B1D EP3666797 Signed-
Jun 23, 2023B1C EP3666797 Signed-
Jun 23, 2023B1B EP3666797 Signed-
Jun 23, 2023B1A EP3666797 Signed-
Jun 23, 2023A1F Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1E Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1D Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1C Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1B Wo 026558 Pct Application As Filed Signed-
Jun 23, 2023A1A Wo 026558 Pct Application As Filed Signed-
Jun 20, 2023Panel Appointment-
Jun 2, 2023Statementofrevocation-
Jun 2, 2023Formal Checks Notification Of Positive Outcome-
Jun 1, 2023Sanofi V Amgen Revocation Action EP3666797 Signed V2-
Jun 1, 2023Letter To Registry Sanofi V Amgen Uploading Issues On Signed-
Jun 1, 2023.06.01 Letter To The Upc Lodging Of Revocation Action-

More cases involving EP3666797B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_3214/2025Jan 21, 2025Redacted Natural Person NameAmgen, Dehns, Redacted Natural Person Name, Sanofi Aventis Deutschland, Sanofi Aventis Groupe, Sanofi Winthrop Industrie
APL_51679/2024Sep 13, 2024AmgenSanofi Aventis Deutschland, Sanofi Aventis Groupe, Sanofi Winthrop Industrie
APL_51683/2024Sep 13, 2024AmgenRegeneron Pharmaceuticals

More cases involving Sanofi Aventis Deutschland

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_33148/2025Jul 17, 2025Sanofi Aventis DeutschlandStada Arzneimittel, Stada Nordic, Stadapharm
ORD_22245/2025May 11, 2025Sanofi Aventis DeutschlandAccord Healthcare, Accord Healthcare AB, Accord Healthcare Italia, Accord Healthcare SLU
ORD_22246/2025May 11, 2025Sanofi Aventis DeutschlandBetapharm Arzneimittel, DR Reddys, Reddy Pharma

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
App_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -